Who
David Duane House
SVP, Finance, and PFO
Company insider
Files Form 4 as: SVP, Finance, and PFO, Armata Pharmaceuticals.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Oct 2024
- Last trade
- 9 Mar 2026
- Last filed
- 11 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —109,885 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —109,885 at $0.00 | filing |
| 5 Feb 2025filed 7 Feb 2025 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 2 Oct 2024filed 3 Oct 2024 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.